These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 15113326

  • 1. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO, Carricajo A, Delavenna F, Recule C, Fonsale N, Manquat G, Raffenot D, Rogeaux O, Aubert G, Tous J.
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [Abstract] [Full Text] [Related]

  • 2. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A, Association of Hospital Bacteriologists, Virologists and Hygiene Professionals.
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [Abstract] [Full Text] [Related]

  • 3. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
    Pina P, Marliere C, Vandenesch F, Bedos JP, Etienne J, Allouch PY.
    Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
    [Abstract] [Full Text] [Related]

  • 4. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C, Denis O, Struelens MJ.
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [Abstract] [Full Text] [Related]

  • 5. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.
    Robert J, Bismuth R, Jarlier V.
    J Antimicrob Chemother; 2006 Mar; 57(3):506-10. PubMed ID: 16410265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.
    N Engl J Med; 1999 Feb 18; 340(7):493-501. PubMed ID: 10021469
    [Abstract] [Full Text] [Related]

  • 9. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital.
    Garnier F, Chainier D, Walsh T, Karlsson A, Bolmström A, Grelaud C, Mounier M, Denis F, Ploy MC.
    J Antimicrob Chemother; 2006 Jan 18; 57(1):146-9. PubMed ID: 16286482
    [Abstract] [Full Text] [Related]

  • 10. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B, Ercis S, Menemenlioglu D, Colakoglu S, Hasçelik G.
    J Antimicrob Chemother; 2005 Sep 18; 56(3):519-23. PubMed ID: 16046461
    [Abstract] [Full Text] [Related]

  • 11. [Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: a Belgian hospital].
    Piérard D, Vandenbussche H, Verschraegen I, Lauwers S.
    Pathol Biol (Paris); 2004 Oct 18; 52(8):486-8. PubMed ID: 15465269
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
    Fitzgibbon MM, Rossney AS, O'Connell B.
    J Clin Microbiol; 2007 Oct 18; 45(10):3263-9. PubMed ID: 17687008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.
    Trakulsomboon S, Danchaivijitr S, Rongrungruang Y, Dhiraputra C, Susaemgrat W, Ito T, Hiramatsu K.
    J Clin Microbiol; 2001 Feb 18; 39(2):591-5. PubMed ID: 11158112
    [Abstract] [Full Text] [Related]

  • 16. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 18; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 17. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
    Młynarczyk A, Młynarczyk G, Łuczak M.
    Med Dosw Mikrobiol; 2003 Nov 18; 55(3):209-17. PubMed ID: 14702662
    [Abstract] [Full Text] [Related]

  • 18. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
    Udo EE, Al-Sweih N, Dhar R, Dimitrov TS, Mokaddas EM, Johny M, Al-Obaid IA, Gomaa HH, Mobasher LA, Rotimi VO, Al-Asar A.
    Med Princ Pract; 2008 Nov 18; 17(1):71-5. PubMed ID: 18059105
    [Abstract] [Full Text] [Related]

  • 19. Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin.
    Heym B, Le Moal M, Armand-Lefevre L, Nicolas-Chanoine MH.
    J Antimicrob Chemother; 2002 Sep 18; 50(3):323-9. PubMed ID: 12205056
    [Abstract] [Full Text] [Related]

  • 20. Comparison of four methods for detection of teicoplanin resistance in methicillin-resistant Staphylococcus aureus.
    Charlesworth R, Warner M, Livermore DM, Wilson AP.
    J Antimicrob Chemother; 2006 Jul 18; 58(1):186-9. PubMed ID: 16641117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.